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AbStrAct
The objective of this study was to establish the association of plasma fibronectin in saliva of pregnant women with history 
of miscarriage(s). A total of 25 pregnant women with history of miscarriage(s) were recruited at the Antenatal Clinic 
of University Malaya Medical Centre (UMMC), Kuala Lumpur as the test group and 16 pregnant women without any 
history of miscarriage served as control. All the subjects fulfilled a set of inclusion and exclusion criteria. Periodontal 
examination was performed to determine subjects’ periodontal status. Saliva samples were collected and enzyme-linked 
immunosorbent assay (ELISA) was used to detect the plasma fibronectin in these samples. Mann-Whitney test was used 
to determine the significance of differences seen. The study showed a statistically significant higher median plasma 
fibronectin level in the saliva samples of the test group with a median level of 0.10 µg/mL compared with the control 
group with a mean value of 0.00 µg/mL (p-value =0.023). However, there was no significant difference in the level 
of plasma fibronectin in the saliva samples of pregnant women with chronic periodontitis compared with the group 
with healthy gingiva (p-value= 0.118). As a conclusion, there was a positive association between plasma fibronectin 
in saliva of women and history of miscarriages compared with the control group in this case study. 
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AbStrAK
Objektif kajian ini adalah untuk melihat hubung kait antara fibronektin plasma di dalam air liur ibu mengandung 
dengan sejarah keguguran. Seramai 25 ibu mengandung dengan sejarah keguguran di Klinik Ibu Mengandung Pusat 
Perubatan Universiti Malaya, Kuala Lumpur telah dikenal pasti sebagai kumpulan kajian manakala seramai 16 lagi 
ibu mengandung tanpa riwayat keguguran dijadikan kumpulan kawalan. Kesemua subjek kajian menepati kriteria 
yang telah ditetapkan. Pemeriksaan periodontium telah dilakukan bagi mengenal pasti status kesihatan periodontium 
mereka. Sampel saliva mereka dianalisis menggunakan ujian ‘enzyme-linked immunosorbent assay’ (ELISA) untuk 
mengesan kandungan fibronektin plasma. Ujian Mann-Whitney digunakan bagi menganalisis data. Keputusan 
mendapati aras purata fibronektin plasma di dalam kumpulan kajian adalah melebihi berbanding purata fibronektin 
plasma dalam kumpulan kawalan. Walau bagaimanapun, tiada perbezaan ketara yang ditemui bagi purata fibronektin 
plasma antara kumpulan subjek yang mempunyai penyakit periodontitis kronik berbanding subjek yang mempunyai 
periodontium yang sihat. Kesimpulannya, kajian ini menunjukkan bahawa terdapat hubung kait yang positif antara 
aras fibronektin plasma di dalam saliva subjek dengan riwayat keguguran. 
Kata kunci: Air liur; fibronektin plasma; keguguran; penyakit periodontium
introDuction
History of miscarriages has an impact on the outcome of 
future pregnancy. it has been established as one of the 
significant risk factors for adverse pregnancy outcomes 
including recurrent miscarriage (regan et al.1989) and 
preterm labour (Mercer et al. 1999). A recent study showed 
that a woman who has had miscarriage in their initial 
pregnancy was at a higher risk of developing obstetric 
complications such as pre-eclampsia, preterm labour and 
low birth weight babies (bhattacharya et al. 2008).
 the knowledge of risk factors is important in 
recognizing an individual’s susceptibility to adverse 
pregnancy outcomes. traditionally, the patients at risk 
can be identified by taking a thorough medical and 
obstetrical history. However, history alone has low 
sensitivity. researches in these areas are being focussed at 
identifying host susceptibility using various host markers 
to aid in the prediction of adverse pregnancy outcomes. 
one of the important markers that had been widely used 
to predict preterm labour was foetal fibronectin from the 
vaginal swabs of pregnant women (Leitich & Kaider 2003; 
Lockwood et al. 1991; Shennan et al. 2005). 
 Fibronectin is a glycoprotein present in blood, 
connective tissue matrix and on cell surfaces. it can exist 
in the body fluids as a soluble form or as an insoluble form 
in the connective tissue matrix protein (ruoslahti 1981). it 
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acts as a component for cellular adhesion to surrounding 
matrix as fibronectin possesses specific binding sites for 
collagen (Kleinman et al. 1978), fibrinogen (Ruoslahti 
& Vaheri 1975) and heparin (Stathakis & Mosesson 
1977). Fibronectin was also incorporated into blood clots 
(ruoslahti & Vaheri 1975) and was assumed to have the 
ability to bind to fibrin by providing adhesive matrix for 
cells to grow in the blood clot (ruoslahti 1981). 
 Fibronectin had been used in medical research as 
a marker for the presence of sepsis (ruiz Martin et al. 
2004) to monitor the severity of hepatic inflammation 
(Kandemir et al. 2004) and to detect cancer (Menendez et 
al. 2005). Similarly, the presence of plasma fibronectin in 
saliva samples may be an indicative of systemic disease 
and thus it could be used as a host marker for certain 
pathological condition as well as being a marker for local 
tissue destruction as in periodontal disease (babu et al. 
1983; Lopatin et al. 1989). 
 Fibronectin was also found in stimulated whole saliva 
(babu et al. 1983). However, it was not known whether the 
fibronectin originated from salivary glands or from gingival 
exudates. Since gingival exudates contains several plasma 
proteins, plasma fibronectin was assumed to be one of the 
component in the gingival crevicular fluid since fibronectin 
was then detected in the samples of whole saliva, gingival 
crevicular fluid and gland-specific saliva excluding parotid 
gland (tynellius-brathall et al. 1986). From the study, they 
found that the amount of fibronectin per μg protein did not 
differ significantly between plasma and gingival crevicular 
fluid. The association of fibronectin with pathogenesis 
of periodontal disease and whether it gave an impact on 
healing of periodontal structures or not, was inconclusive 
because there were no statistically significant differences in 
concentrations of fibronectin in human saliva between pre 
and post-periodontal treatment (tynellius-brathall 1988). 
 the aims of the study were to determine the association 
of plasma fibronectin in the saliva of pregnant women with 
a history of miscarriages and to determine the association 
of plasma fibronectin in saliva with periodontal disease.
MAteriALS AnD MetHoDS
this is a case-control study which involved 41 consecutive 
pregnant women with past history of miscarriage in their 
second trimester up to 32 weeks of gestation who came 
for antenatal check-up in Antenatal clinic, university 
Malaya Medical centre (uMMc) Kuala Lumpur. the 
study was carried out from october 2007 until June 
2008. Pregnant women who were smokers, had history 
of drug abuses, had multiple foetuses and presence of 
serious medical or systemic conditions were excluded 
from the study. All subjects aged between 18 and 42 years 
old and had consented for the study were then asked to 
undergo periodontal examination at the Periodontology 
Postgraduate. their periodontal status was recorded. 
Periodontal disease in the form of chronic periodontitis was 
diagnosed based on the presence of these criteria: Probing 
pocket depth of ≥5 mm at ≥4 sites for the whole mouth 
and bleeding on probing at these sites. in addition, the 
information on their history of miscarriage(s) was obtained 
from the medical records. the study was conducted 
with the approval from the Medical ethics committee 
of university Malaya Medical centre (no 607.1). 
 each subject was asked to expectorate into a sterile 
plastic tube and a 4 mL unstimulated whole saliva was 
collected which was then frozen at -80°c for analysis. 
the collection of the saliva samples was standardized 
before 12.00 pm to avoid differences in the content 
caused by circadian rhythm and done prior to periodontal 
examination to avoid blood contamination to the samples. 
 The level of salivary fibronectin in each samples were 
analysed using a commercially-available enzyme-linked 
immunosorbent assay (eLiSA) kit (iMucLone) of murine 
monoclonal antibody to human fibronectin. 
 Statistical Package for Social Science (SPSS) Version 
16.0 was used to analyze the results. Since the fibronectin 
level in the saliva displayed a non-normal distribution, the 
Mann-Whitney test was used to determine the significance 
of the difference between the test and control groups. the 
statistical significance was set for a p-value of ≤ 0.05. 
reSuLtS
DeMogrAPHic ProFiLeS oF tHe SubJectS
the sample consisted of 25 consecutive healthy pregnant 
women (group A) who came for antenatal check-up and 
had history of previous miscarriage(s) which occurred 
between the 6th and the 27th week and subsequent 16 
healthy pregnant women (group b) who had no previous 
miscarriage and who has had deliveries at more than 36 
weeks. Fourteen women in group A had one miscarriage 
and the other eleven of them have experienced twice. 
none of the subjects have experienced more than twice 
miscarriage(s) (table 1). 
 All 41 subjects examined were included in this case 
study. Majority of the subjects were Malays with 33 
(54.9%), followed by indians 7 (23.4%) and chinese 1 
(20.0%) as presented in table 2. the average (mean and 
median) levels of fibronectin were higher among subjects 
in group A and c as compared with subjects in group b 
and D. 
PLASMA Fibronectin in teSt AnD controL grouPS
using Mann-Whitney test, our results showed that 
there was a significant difference in the level of plasma 
fibronectin in the saliva of group A and B (table 3 and 
Figure 1). 
 the group A subjects were further analyzed using 
Mann-Whitney test. the result showed that the difference 
in fibronectin level was not significant between those 
diagnosed with periodontal disease and healthy subjects. 
the median gap was rather small. However, for group b 
subjects, there was a significant difference in fibronectin 
level between periodontal disease and healthy subjects. 
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the median gap was larger for these two groups (table 4). 
Combining the two groups did not produce any significant 
difference between subjects with periodontal disease and 
healthy periodontium in the value of fibronectin with the 
p-value 0.118. 
DiScuSSionS
traditional teaching uses medical or obstetric history to 
identify women at risk of miscarriage. Advanced maternal 
age has also been to play a role. Researches on definitive 
markers to identify women at risk of miscarriages are too 
few. A host response marker would be useful to enable us to 
recognize an individual who is susceptible to miscarriage. 
unfortunately, markers for miscarriage have not been as 
well-established as compared with those currently used in 
obstetrics for preterm labour.
 Apart from miscarriage, the increased levels of plasma 
fibronectin have been associated with other adverse 
pregnancy outcomes such as pre-eclampsia (Dreyfus et 
al. 1998; Friedman et al. 1994; Stubbs et al. 1984) and 
pre-term labour (zygmunt et al. 1997). the level of plasma 
fibronectin is also higher in maternal plasma samples of 
patients with preterm delivery as compared with normal 
pregnant women (zygmunt et al. 1997). the results from 
this study illustrates that the fibronectin level of pregnant 
women with past history of miscarriage(s) is statistically 
significant higher than in the group that never had a 
miscarriage. 
 Even though the amounts of fibronectin detected was 
low in both test and control groups, it is generally accepted 
that the fibronectin levels in saliva and gcF are lower than 
that of the plasma (Lopatin et al. 1989), which is usually at 
1% below the average plasma level. From this study, the 
origin of plasma fibronectin was probably due to a systemic 
condition. The mean value of plasma fibronectin in test 
subjects without periodontal disease was higher compared 
with control subjects without periodontal disease. this 
demonstrates that the prevailing high fibronectin level 
even in healthy subjects of test group was not entirely 
due to local tissue destruction. in group b, the high value 
of plasma fibronectin in those with periodontal disease 
tAbLe 1. Distribution of subjects according to groups
Periodontal status
Periodontal disease Healthy Total
History of miscarriage(s)
Yes 11 14 25
(Group A)
No 5 11 16
(Group B)
Total 16
(Group C)
25
(Group D)
41
tAbLe 2. Demographic profiles of the subjects based on miscarriage(S) history and periodontal status
History of 
miscarriage
Periodontal status n Malay chinese indian Mean Age Mean 
fibronectin 
level
Median 
fibronectin 
level
yes
Periodontal disease
Healthy
Total
11
14
25
7
11
18
1
0
1
3
3
6
29.55
29.07
29.28
0.42
0.37
0.39
0.15
0.09
0.10
no
Periodontal disease
Healthy
Total
5
11
16
4
11
15
0
0
0
1
0
1
30.40
30.82
30.69
0.25
0.01
0.09
0.18
0.00
0.00
total
Periodontal disease
Healthy
Total
16
25
41
11
22
33
1
0
1
4
3
7
29.81
29.84
29.83
0.37
0.21
0.27
0.16
0.00
0.19
tAbLe 3. Plasma fibronectin in saliva between group A and B
History of miscarriage n Median fibronectin level (μg/mL) p-value
group A 25 0.1 0.0234
group b 16 0
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was probably due to local tissue destruction as there was 
significant difference of fibronectin levels between the 
periodontal disease and healthy subjects. this was probably 
due to the fact that there is an increased permeability of 
the blood vessels in the periodontium during periodontal 
disease. This results in the increase in fibronectin exudation 
into the surrounding tissue, flushing into crevice region and 
ending up in the saliva.
 Plasma fibronectin is synthesized by endothelial cells 
and forms a layer between vascular endothelium and the 
basement membrane (Mosesson & Armani 1980). the 
increase in plasma fibronectin can be due to endothelial 
damage or alteration in endothelial function (Stubbs et 
al. 1984). this alteration in endothelial function caused 
thrombus formation and thrombotic abnormalities (clark 
et al. 1999). thrombus formation in blood vessels to 
maternal-foetal environment could lead to failure of foetal 
development as thrombotic events have been postulated 
as one of the possible mechanism in miscarriage (Laird et 
al. 2003). 
 Elevated levels of plasma fibronectin may not only be 
the result of an alteration or damage in endothelial cells, 
but it could also be the causative factor for the vascular 
disturbances, as it has also been associated with thrombotic 
Figure 1. Plasma fibronectin in saliva between group A and B periodontal status
hx of adverse pregnancy outcome
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tAbLe 4. Plasma fibronectin in saliva between groups in relation to periodontal status
History of miscarriage Periodontal status Median fibronectin level 
(μg/mL)
Median gap p-value
yes (group A) Periodontal disease 0.15
Healthy 0.09 0.06 0.889
no (group b) Periodontal disease 0.18
Healthy 0 0.18 0.046
total Periodontal disease 0.16
Healthy 0 0.16 0.118
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events. The interaction of plasma fibronectin with fibrin, 
collagen and activated platelets is important in a thrombotic 
event as evidenced by animal studies where the thrombus 
growth in injured arterioles is delayed with depletion of 
plasma fibronectin (Matuskova et al. 2006). Fibronectin is 
cross-linked to fibrin during thrombus formation and this 
further enhances the stability of the clot (Kamykowski et 
al. 1981).
 Most clinicians agree that a significant number of 
women with miscarriage(s) have a haemostatic disturbance 
in the blood vessels to the foetal-maternal circulatory 
system (younis 1998). this is because pregnancy itself 
is a hypercoaguable state and predisposes to thrombus 
formation and cause placental vascular insufficiency, 
leading eventually to foetal death (younis 1998).  
 our study has some limitations that should be 
considered for future study. First, saliva sample alone is not 
enough to study for the association of plasma fibronectin 
found in the saliva with miscarriage. cervocivaginal swab 
is the other sample that should have been incorporated 
in the study. However, the procedure is only allowed 
for medical officers or midwives. It would be better if 
we could compare the level of fibronectin saliva and in 
cervicovaginal swab of each subjects in order to determine 
the correlation between those two sources of the fibronectin. 
We should also collect the blood samples to compare the 
fibronectin level in saliva and the plasma samples since 
more studies have established the significance relevant of 
plasma fibronectin in plasma samples. 
 Secondly, the diagnosis of periodontal status among 
pregnant women in this study is in very restricted situation 
where it was done mainly based on clinical examination 
and not with the aids of radiograph findings. Chronic 
periodontitis was diagnosed based on the pocket depth 
more than 4 mm in at least 4 sites of the dentition (Van 
der Velden 2000). the diagnosis should involved more 
than 4 sites because four sites is too minimal to show 
the generalized involvement of chronic periodontitis. in 
fact, the periodontal parameter should involved pocket 
depth more than 5 mm with attachment loss at least 4 mm 
(Lopatin et al. 1989). 
 thirdly, the selected cohort may not be suitable since 
it involved only urban population that were generally 
more-educated and aware of their oral health conditions. 
 As a conclusion, there was a positive association 
between plasma fibronectin in saliva of women with history 
of miscarriage but no association was found between 
plasma fibronectin in saliva with periodontal disease in this 
case study. They had a higher level of plasma fibronectin 
compared with the control group. Thus, plasma fibronectin 
in saliva could be a potential marker for clinical diagnosis 
of miscarriage. 
 For future study, we would like to recommend for 
the involvement of a larger sample size from multiple 
centres. the study should be done together with 
representative from obstetrics and gynecology. Serum 
and cervicovaginal swab samples should also be acquired 
from each subject together with the saliva. Fibronectin 
levels from the three sources should then be compared 
among pregnant women that had miscarriages. this could 
show the relevance of fibronectin levels from the saliva 
as a surrogate for the serum levels of the same, indicating 
systemic dissemination of fibronectin. Timing of data 
collection should include those in the early trimesters 
of pregnancy. these women should be followed up until 
the day of delivery or the miscarriage. Sampling should 
be done periodically to detect chronological changes 
in the fibronectin levels of all 3 sampling sites (saliva, 
serum and vagina). Finally, the recruitment of samples 
should ideally be those who have been diagnosed with 
chronic periodontitis prior to conceiving. this is to assure 
the accuracy of the diagnosis of periodontitis, as these 
patients would have had an intraoral radiograph done.
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